GTCM
Gyon Technologies Capital Management Portfolio holdings
AUM
$267M
1-Year Return
11.59%
This Quarter Return
+7.05%
1 Year Return
-11.59%
3 Year Return
+41.48%
5 Year Return
–
10 Year Return
–
AUM
$127M
AUM Growth
+$86.1M
(+208%)
Cap. Flow
+$85.5M
Cap. Flow
% of AUM
67.12%
Top 10 Holdings %
Top 10 Hldgs %
12.46%
Holding
314
New
239
Increased
14
Reduced
16
Closed
45
Top Buys
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$2.45M |
| 2 |
Goldman Sachs
GS
|
$1.9M |
| 3 |
Parker-Hannifin
PH
|
$1.65M |
| 4 |
Amazon
AMZN
|
$1.57M |
| 5 |
Cummins
CMI
|
$1.52M |
Top Sells
| 1 |
American Homes 4 Rent
AMH
|
$2.01M |
| 2 |
Brixmor Property Group
BRX
|
$2.01M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$1.58M |
| 4 |
Highwoods Properties
HIW
|
$1.38M |
| 5 |
Worthington Enterprises
WOR
|
$1.29M |
Sector Composition
| 1 | Financials | 22.46% |
| 2 | Industrials | 14.94% |
| 3 | Healthcare | 14.31% |
| 4 | Consumer Discretionary | 9.57% |
| 5 | Consumer Staples | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Bio-Rad Laboratories Class A
BIO
$7.78B
| $314K | 0.25% |
+609
| New | +$314K |
|
152
Abbott
ABT
$232B
| $312K | 0.24% |
+2,867
| New | +$312K |
|
153
Crown Holdings
CCK
$10.7B
| $309K | 0.24% |
4,026
-6,534
| -62% | -$501K |
|
154
Newmont
NEM
$82.2B
| $309K | 0.24% |
+4,874
| New | +$309K |
|
155
Marvell Technology
MRVL
$55.3B
| $304K | 0.24% |
+7,649
| New | +$304K |
|
156
Starbucks
SBUX
$98.9B
| $301K | 0.24% |
+3,500
| New | +$301K |
|
157
iShares MSCI Mexico ETF
EWW
$1.81B
| $300K | 0.24% |
+8,993
| New | +$300K |
|
158
Apple
AAPL
$3.53T
| $297K | 0.23% |
+2,564
| New | +$297K |
|
|
AQUA
159
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $294K | 0.23% |
+13,878
| New | +$294K |
|
160
GSK
GSK
$79.3B
| $293K | 0.23% |
+6,235
| New | +$293K |
|
161
Algonquin Power & Utilities
AQN
$4.32B
| $291K | 0.23% |
+20,021
| New | +$291K |
|
162
Sonoco
SON
$4.49B
| $291K | 0.23% |
+5,702
| New | +$291K |
|
163
CSX Corp
CSX
$60.6B
| $282K | 0.22% |
+10,899
| New | +$282K |
|
|
ZNGA
164
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $282K | 0.22% |
30,937
+4,629
| +18% | +$42.2K |
|
165
Molson Coors Class B
TAP
$9.81B
| $281K | 0.22% |
+8,368
| New | +$281K |
|
166
Copart
CPRT
$47.9B
| $276K | 0.22% |
+10,512
| New | +$276K |
|
167
Micron Technology
MU
$136B
| $276K | 0.22% |
+5,881
| New | +$276K |
|
168
Edgewell Personal Care
EPC
$1.08B
| $275K | 0.22% |
+9,865
| New | +$275K |
|
169
Fortis
FTS
$24.9B
| $275K | 0.22% |
+6,725
| New | +$275K |
|
170
Bristol-Myers Squibb
BMY
$94.4B
| $274K | 0.22% |
+4,538
| New | +$274K |
|
171
Lamb Weston
LW
$7.75B
| $274K | 0.22% |
+4,134
| New | +$274K |
|
172
Pfizer
PFE
$139B
| $269K | 0.21% |
+7,731
| New | +$269K |
|
173
Ionis Pharmaceuticals
IONS
$9.4B
| $268K | 0.21% |
+5,651
| New | +$268K |
|
174
KBR
KBR
$6.38B
| $268K | 0.21% |
11,972
-7,432
| -38% | -$166K |
|
175
Southern Company
SO
$101B
| $268K | 0.21% |
+4,952
| New | +$268K |
|